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Clinical research within an academic
institution like Jefferson is a complex and
unique endeavor. Beyond the painstaking
procedures, analysis, and publishing is
the leadership and vision, which is where
Assistant Professor David Whellan, MD,
MHS, comes in. Board-certified in both
internal medicine and cardiology, he is also
Director of Clinical Outcomes Research for
the Department of Medicine and Director
of Clinical Research for the Jefferson
Heart Institute (JHI).
Dr. Whellan has extensive experience in
clinical trial design and outcomes research,
having worked with the National Heart,
Lung, and Blood Institute, as well as
industry sponsors, to develop and complete
clinical studies. He also sees patients at
the JHI Advanced Heart Failure and
Cardiac Transplant Center and was recently
named an Associate Editor of the
American Heart Journal.

Chairman
I am always proud
to announce the
exciting new work
our faculty and
staff are doing
to advance and
define the future
of research,
education, and
clinical care.
Highlights of this
issue include: Dr. Whellan and his team on
leading the region in clinical research and
related outcomes; Dr. Most on his German
roots and directing the Laboratory for
Cardiac Stem Cell and Gene Therapy; Dr.
Fink on the Hospitalist Program; and Dr.
Jaffe on the Sleep Disorders Center and its
new state-of-the-art facility here on campus.
I also thank the many generous
organizations and individuals (listed on
pages 5–6), who support our work through
gifts to the Department. Without them we
would be facing an even greater struggle
for disappearing federal grants and
research dollars. We treasure them as
members of the Jefferson family and
welcome them to visit us regularly to
see first-hand all of our latest initiatives.
As the largest and most diverse department
within the University, we have many more
exciting initiatives and updates to share
than we can contain in these few pages.
For this reason we are now including more
in-depth articles on the department website
(www.jefferson.edu/medicine). We look
forward to sharing all of the future
developments, which keep us very hard
at work.

Arthur M. Feldman, MD, PhD
Magee Professor of Medicine and
Chairman of the Department

Continued on page 7
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Patrick Most:
Knocking on the Door for a Cure
Patrick Most, MD, PhD, is an Assistant
Professor and directs the Center for
Translational Medicine’s Laboratory for
Cardiac Stem Cell and Gene Therapy. He
recently sat down with Translations editors
to shed some light on his training in
Germany, his research, and his aspirations
as a clinician.

In 2003, I joined his new lab at Jefferson
for my post-doc and we had two major
breakthroughs. It was exciting to join the
Center in its early days and see it grow
so successfully. In 2004, I returned to
Germany to complete my clinical training,
but Dr. Koch made me an attractive offer
to return afterwards.

You run a lab in Heidelberg as
well as here, yes?

What’s the connection between
what you studied then and what
you are researching now?

Yes — I go back and forth between the
two, since both labs have their unique
advantages, resulting in some synergistic
effects. Two of my former doctoral
students, Mirko Völkers and Sven Pleger,
now both working as physicians at the
University of Heidelberg, help me run the
lab there. And for now, my wife’s career
keeps her in Germany, so I get back as
often as my work here allows me.

Where did you grow up and do
your training?
I was born just outside Frankfurt in a small
town, but I studied medicine in Heidelberg.
I then started my doctoral thesis in the lab
of Dr. Katus, at that time the senior staff
of the cardiology division at the University
of Heidelberg. I finished in 1996 and then
went with him to the University of Lübeck,
where he became head of the medical
department. This coincided with the start
of my clinical education as a physician.

How did you come to the Center
for Translational Medicine at
Jefferson?
A friend from Hamburg put me in touch
with Dr. Walter Koch [now Director of
the Jefferson Center for Translational
Medicine], who was then at Duke, doing
research in gene transfer. We were
interested in gene transfer strategies
to intensify our research, and this new
technique was almost at its height. So
starting in 2001, I joined Dr. Koch’s lab
for the first of several successful projects.

The protein we are currently working on
was already the subject of my doctoral
thesis 11 years ago. Looking back, it’s
fascinating that we started almost from
scratch — literally knowing nothing 11
years ago — and now are knocking on
the door of a clinical breakthrough. We
now know that this cardiac-specific protein
(S100A1) has the ability to enhance
cardiac function without any negative
consequences. We discovered that failing
hearts lose most of their S100A1 protein,
which causes them to fail more rapidly.
And now that we understand the molecular
mechanism, we are pushing forward to
develop this as therapy to support the failing
heart and restore its contractile function.

How does your work benefit from
training both as a clinician and
as a basic researcher?
The two have definitely guided my research
interests. My clinical background puts me
in the unique position to combine medical
needs with hypothesis-driven research to
find new ways to cure our patients. The
challenge of heart failure — with a mortality
rate of 50%, which rivals cancer mortality —
is that there are currently no therapies that
target defective cardiac function, only
ways to avoid or suppress the maladaptive
compensatory reactions of the body if a
patient has already sustained damage. So
I sought a research path that was going to
break the vicious cycle and would actually
enhance cardiac function and improve
survival by directly targeting the mechanisms
that cause hearts to fail.

https://jdc.jefferson.edu/translations/vol3/iss2/1
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Assistant Professor Patrick Most, MD, PhD,
directs the Center for Translational Medicine’s
Laboratory for Cardiac Stem Cell and
Gene Therapy.

What is your hope that the
outcome of this research will
offer patients?
I am currently following a new lead showing
that one tiny end of S100A1 protein can
be chemically synthesized and penetrate
cardiomyocytes (heart cells) and then
improve their function, protect from
arrhythmias, and even prevent death of
those cells. With this simpler approach,
we are advancing to animal models.
I’m hoping that this could constitute an
alternate means to the same end, but
could be administered through an IV. My
hope is that I will meet the first patient
to receive these therapies I have been
developing over the past decade. ■
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The Problem of Rest
Continued from page 4

many people, including physicians, still
view sleep disorders as largely psychologically
based,” he says, so they can frequently
can go unchecked or misdiagnosed. “Our
goal,” says Jaffe, “is to raise awareness
of talking to patients about sleep during
regular health assessments, since treatments
can have a tremendous positive impact on
people’s overall health.”
In June 2007, the Center opened its new
state-of-the-art facility at 9th and Walnut
Streets on the Jefferson Center City campus.
Patients who require overnight evaluations
and monitoring sleep in one of ten
bedrooms, which not only are equipped
with the most advanced sleep-monitoring
technology, but are also hotel standard:
with private baths, flat-screen televisions,
and individual temperature controls. The
Center also offers a kitchen, study and
lounge area, and indoor parking.
To learn more about sleep disorders and
the Jefferson Sleep Disorders Center visit
us online at www.jeffersonhospital.org/
psychiatry/article11031.html. ■

Jefferson Clinical Research Program
Continued from page 1

The first component of the Cardiology
Clinical Research Program is outcomes
research, which creates databases that
enable researchers to do retrospective
analyses. To implement the outcomes
research projects, Dr. Whellan works
with Suzanne Adams, RN, MPH, Assistant
Director of Clinical Outcomes Research,
and a number of Jefferson investigators
in the Center for Translational Medicine;
the Center for Research in Medical
Education and Health Care, and the
Biostatistics Division of Pharmacology and
Experimental Therapeutics. “Once the data
is compiled into an analysis dataset,” Dr.
Whellan says, “physicians-in-training can
explore different hypotheses with mentors
and statisticians and experience the entire
research process, from developing a
protocol and IRB submission to presenting
results at national meetings.”
The second component involves design
and development of prospective research
projects initiated by Jefferson faculty.

Published by Jefferson Digital Commons, 2009

Helping Patients Write New
Life Stories
Continued from page 3

small intestine — an area of bowel that
could previously be evaluated only by x-ray.
A specialist in ulcerative colitis and Crohn’s
disease, as well as microscopic colitis, Dr.
Kozuch now leads Jefferson’s IBD Diagnostic
and Treatment Center. She and her
colleagues from the GI Division as well
as the departments of Surgery, Radiology,
and Pathology offer a multidisciplinary
approach to treatment and provide
comprehensive, cutting-edge care for
patients suffering from both of these chronic
conditions. The Center staff also conducts
clinical trials to evaluate new medications.

Assistant Professor Patricia Kozuch, MD, directs the
Irritable Bowel Disease Diagnostic and Treatment
Center at Jefferson.

Dr. Kozuch’s own research interests include
trying to better delineate the factors that
contribute to the established increased risk
of colon cancer in patients with ulcerative
colitis and Crohn’s disease of the colon.
“The more we understand, the more we
can do for people,” she says. “It’s incredibly
exciting to be involved as we make
discoveries that will ultimately change the
lives of the people we care for every day.”

For more information about the IBD
Center, visit www.jefferson.edu/gi/
institute/centers1.cfm. ■

JHI currently has several such projects that
are funded. “We provide the infrastructure,
from development of proposals and budgets
to implementing the study, collecting data,
performing analyses, and writing up the
results,” Dr. Whellan explains. A third
component is the JHI Cardiovascular
Research Group (JCRG), managed by
Elizabeth Grace, RN, which supports both
industry-sponsored and investigator-initiated
clinical trials by managing regulatory
documents, enrolling subjects, and managing
research accounts.

MD, Assistant Professor of Cardiothoracic
Surgery, used a database from the University
HealthSystem Consortium — an academic
benchmarking agency in which the
University participates — to evaluate clinical
outcomes in patients undergoing off-pump
coronary bypass surgery and given Plavix
(clopidogrel). They presented results at the
American College of Cardiology Scientific
Meetings in New Orleans this year. A related
investigator-initiated proposal is under review
by sponsors to fund a multi-center trial,
which would include enrollment at Jefferson
Hospital and other JCTG-managed sites.

Dr. Whellan also directs the Jefferson Clinical
Trials Group (JCTG), overseen by Deborah
Moretti, RN. This academic research
organization (ARO) manages large clinical
trials at a number of other academic and
clinical centers throughout the U.S. They
are currently preparing two studies that
evaluate new therapies for patients with
acute heart failure.

“JHI is positioning itself to provide a full
range of clinical research opportunities
for faculty, fellows, residents and medical
students,” says Whellan. “We are in an
exciting phase of development in supporting
research that we hope will improve the
care and health of our patients.” ■

Dr. Whellan’s goal is to integrate as many
University-wide components as possible
and develop clinical research initiatives. For
example, an outcomes research group that
includes Ms. Adams and Scott Silvestry,
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Supporting the Future

Candido E. Rivera
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Anthony J. DiMarino, Jr., MD

Honorary Gala
Celebrates GI Chief
At a gala held October 11, 2007, Thomas
Jefferson University (TJU) and Thomas
Jefferson University Hospital (TJUH)
honored Anthony J. DiMarino, Jr., MD,
with its Achievement Award in Medicine.
This award goes to “individuals who have
achieved and maintained excellence in
their profession and who have actively
contributed to the growth and development
of their field.”
A preeminent consultative gastroenterologist,
Dr. DiMarino joined Jefferson in 1996 as
the William Rorer Professor of Medicine
and Chief of the GI Division. He has been
honored as “Physician of the Year” by the
Delaware Valley Chapter of the Crohn’s &
Colitis Foundation of America, as a “Top
Doc” in Philadelphia Magazine (1991–
2007), and as one of America’s “Best
Doctors” by Castle Connolly Medical, Ltd.
The reception and dinner, held at the
Marriott Hotel Grand Ballroom in Center
City, was co-chaired by Ira Brind, Joanne
and Jack Dorey, Marjorie and Jeffrey
Honickman, Adele and Harold Schaeffer,
and Tonia and Fred Tecce. The event also
recognized Lynne and Harold Honickman
with the Award of Merit.
This is the second time in three years that
a Department of Medicine Division Chief
has been honored by the hospital and
university in this capacity. Bernard L. Segal,
MD, was similarly recognized in 2005. ■

Michael P. Reilly
Verna W. Rich

https://jdc.jefferson.edu/translations/vol3/iss2/1
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Hospitalist Program: Care Tailored to Being There
It was not so many years ago that the
word “hospitalist” would inspire blank
stares, although this model of “hospital
specialists” was developed a decade ago.
The Jefferson Hospitalist program continues
to expand, and the 2007–08 academic
year includes the addition of three new
physicians, two of whom were recently
graduated residents at Jefferson.
“Jefferson picked up early on this model
for care,” says Hospitalist Program Director
James Fink, MD. “But over the past few
years the institution has invested significantly
in the program, to ensure the best possible
care for patients, the most efficient use of
hospital resources, and excellent training
for its medical students and residents.”
Dr. Fink explains that “before hospitalist
medicine, the attending physicians would
come into the hospital only as needed
to check on patients and order tests, and

then might not be available to patients or
families until the next day.” But by definition,
hospitalists are on-site specialists focusing
on in-patient care and efficiency — a critical
role given the costs and other realities of
the current health care climate.

these are teaching services, on which
the physicians round for 2-3 hours every
morning, instructing their residents while
they see patients. Hospitalists are then
available to their patients and resident
teams — throughout the day.

The Hospitalist program assists specifically
with case management issues, from
coordinating follow-up care to helping
patients handle insurance. The program
also plans to become more involved in
areas like patient safety and improving the
transition of patients into and out of the
hospital. “This is a natural progression,”
says Dr. Fink, “given that we are stationed
in the hospital. We act as advocates for the
patient and, simultaneously, help to advise
the hospital on its procedures and resources.”

One advantage of hospitalist medicine, says
Fink, is that physicians can choose from a
range of niches based on their interests. For
example, Jeff Riggio, MD, has leveraged his
interest in technology to focus on how best
to address patients’ needs using the latest
computer and software systems available.
Two others focus especially on case
management, working closely with social
workers and staff. Some concentrate on
medical consultation either at TJUH or at the
Jefferson Hospital for Neuroscience, where
the hospitalist group co-manages the
patients admitted to the neurosurgery service.

The Hospitalist program oversees
approximately 100 patients every day
through five in-patient services; four of

“This is a young and extremely motivated
group,” Dr. Fink says, “and we look forward
to continuing to provide great care to our
patients, excellent teaching to our students
and residents, and expanding our roles as
physicians who are integral to the future
of health care at TJUH.” ■
Jefferson Hospitalists (left to right): Walter
Kraft, MD; Mary deVry, CRNP; Elizabeth
Teperov, MD; Donna Williams, MD;
Gretchen Diemer, MD; James Fink, MD;
Taki Galanis, MD; Kimberly Covington, CRNP;
Jessica Salt, MD; and James Davis, MD

Gastroenterology and Hepatology

Helping Patients Write New Life Stories
“I love learning each patient’s unique history,
personally and medically,” says Assistant
Professor Patricia Kozuch, MD. Having
joined the Division of Gastroenterology
and Hepatology (GI) in September 2006,
she focuses on the all-too-common
Inflammatory Bowel Disease (IBD).
“Attending to these nuances,” says Dr.
Kozuch, “helps me to devise treatments
that are more artful and individualized.”

Dr. Kozuch first became interested in
gastroenterology as a medical student
at Cornell University. Later, she pursued
an advanced fellowship in IBD at the
University of Chicago Hospitals with
Stephen Hanauer, MD, who leads an
internationally recognized IBD referral
center and team of doctors.
“The study of IBD is truly burgeoning,”

Dr. Kozuch explains. “And a greater
understanding of disease pathogenesis
translates into the development of new
medical therapies, which provide us with
a greater range of equipment, technology,
and medication.” She notes that recent
technology such as capsule and doubleballoon endoscopy has significantly
improved physicians’ ability to diagnose
IBD and other diseases that affect the
Continued on page 7
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Pulmonary and Critical Care

The Problem of Rest: Jefferson Sleep
Disorders Center
We humans spend a third of our lives
asleep. We need close to eight hours a
day to function productively and maintain
good health. “Yet 70 million people a year
have difficulty sleeping and approximately
60 percent suffer from a chronic sleeprelated disorder,” says Fredric Jaffe, DO,
Assistant Director of the Jefferson Sleep
Disorders Center as well as Assistant
Professor of Medicine in the Division of
Pulmonary and Critical Care Medicine.
Since 1978, the Jefferson Sleep Disorders
Center — now a joint initiative of TJUH
and Jefferson University Physicians — has
been working to understand and treat rare
and common sleep disorders, including
sleep apnea syndromes, insomnia and
narcolepsy, sleep walking and talking,
head banging, and nightmares.

Jefferson’s program was the first of its kind
in the Delaware Valley. Although more
than 30 centers now exist in the area, the
center continues to distinguish itself by
approaching sleep from a multidisciplinary
and team-based perspective.
“Every patient presents with unique and
complex medical needs,” says Dr. Jaffe.
“Our job is to provide the best diagnostic
evaluation and appropriate course of
treatment in collaboration with other
medical disciplines.” Each patient receives
an objective physical assessment using the
latest technology that examines everything
from neurological and pulmonary conditions
to potential otolaryngological and
psychiatric causes.

Frederic Jaffe, DO, and a technician review a
study in the Sleep Disorders Center control room.

The Center staff also strives to educate
medical students and other physicians
about the pervasiveness and intricacies of
sleep disorders. “Unfortunately, patients
and their physicians rarely discuss sleep
habits during routine office visits or even
while patients are in the hospital,” Dr.
Jaffe says. “Although sleep science has
advanced greatly over the last century,
Continued on page 7

Education
For Chief Residents It’s All in a Day’s Work
The daily responsibilities of the department’s
chief residents might daunt even the most
hardworking among us. Elected by their
peers, they are responsible for administrative
and educational duties that include planning
a daily morning report, conferences, and
weekly lectures. Additionally, they coordinate
grand rounds, represent the department on
numerous committees, and run the weekly
morbidity and mortality report, in which
residents discuss and learn from mistakes.
Sharing these responsibilities this year are
the 2007–2008 chief residents: Mary Kate
McCullen, MD; Andrew Rose, MD; and
Joanna Kipnes, MD.

Dr. McCullen

Dr. McCullen, a
Havertown, PA,
native and graduate
of Jefferson Medical
College (elected to
honor medical society
Alpha Omega Alpha, or
AOA), plans to specialize
in Endocrinology, with
a focus on diabetes,

“because it can be such a debilitating
disease if not controlled,” says Dr. McCullen.
In addition to spending time with her
husband — a Jefferson anesthesiology
resident — the classical violinist even squeezes
in some hours of practice each week.
Before graduating
(AOA) from Columbia
University College
of Physicians and
Surgeons, Dr. Rose
worked as a
pharmaceutical
researcher. “It’s much
more satisfying to work
with patients,” he says.
Dr. Rose
Next year, Dr. Rose will
do a fellowship in cardiology and critical
care. He volunteers as editor of the
Jefferson Medical Forum, resident advisor
for the hospital’s Rapid Response Team,
and executive member of the hospital’s
curriculum committee. He’s also raised
more than $40,000, through walks and
marathons, for amyotrophic lateral sclerosis

https://jdc.jefferson.edu/translations/vol3/iss2/1
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(ALS) research in honor of his brother, who
was recently diagnosed with ALS. This
fall Dr. Rose and his wife, a chief resident
in pediatrics at Children’s Hospital of
Philadelphia, welcomed their first child.
Internal Chief Medicine
resident Dr. Kipnes
has an MS in clinical
pharmacology from
Thomas Jefferson
University and an MD
(AOA) from Jefferson
Medical College. She
plans to continue with
Internal Medicine and
Dr. Kipnes
is interested in the
Hospitalist track. She serves on the
Jefferson Doctor-Nurse Communication
Committee and Women’s Health
Subcommittee and volunteers with Jeff
HOPE, a student-run health program
for Philadelphia’s homeless. She and her
husband, also a physician, are new parents
of twin girls. ■
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Supporting the Future
The Department of Medicine is grateful
to all of our donors for their generous
support of our centers, faculty, research,
and education in the past year.
Charitable gifts support the amazing work
our physicians do every day and help the
department to continue to expand its

legacy as a leader in the region. This help
makes it possible for us to recruit the finest
physicians and residents, educate the
most talented students, and advance our
longstanding tradition of translating our
patients’ problems today into the next
generation of medical care. Thank You!

To learn more about giving opportunities
within the Department of Medicine,
please contact Margaret Fala, Director of
Development, Department of Medicine at
The Jefferson Foundation, at 215-955-7556
or margaret.fala@jefferson.edu.

Gifts to the Department of Medicine
September 1, 2006, through October 1, 2007
Susan P. Abraham

Thomas J. Connelly

Lawrence M. Guenzel

William C. Ackerly

Gibbons G. Cornwell

Richard Guggenheim

Paul E. Aloe

Judith H. Cross

The Mary B. & Alvin P. Gutman Fund

The Estate of Irmgard Altenbach

Iris C. Cutler

Hie-Won Y. Hann

Irving Altman

John V. D’Allessio

Marion Hazzard

America’s Charities

Kevin J. Daviau

Arthur E. Helfand

Joan A. Ashley

Martha E. Diebold

Walter H. Herbert

William J. Auve

Jeanne S. DiMarino

Hobart Armory, Hare Honor Medical Society

Joseph H. Ball

Irene Donlan

Dennis H. Hoffa

The Barnes Study Group

Jan E. Dubois

Chen I. Huang

Doris G. Bartuska

Edward Elisio

Jerry P. Hurvitz

Mary E. Basso

Christopher Elliott

William A. Hutchinson

Lisa A. Baum

Joel Elliott

Jackeline Iacovella

Cynthia A. Bayer

Ronald Ervais

Joan F. Jaffe

J. E. Berk

Eugene Feiner

Jewish Federation of Greater Philadelphia

Joan L. Blum

Fell Faculty Sunshine Fund

Edward Jutkowitz

Martin J. Blumberg

Edward Fernberger

Charles Kahn

Hudson R. Bollinger

Scott H. Fertels

The Kahn Testamentary Foundation

John R. Bollinger

Robert J. Fieldsteel

Gregory C. Kane

Robert L. Boyd

Gordon B. Fink

Michael W. Kaplinsky

John R. Boyer

Howard E. First

Grant W. Keller

David A. Brandt

Kay E. Fisher

Hye Hyun Kim

Brandywine Valley Hemophilia Foundation

Arthur J. Floyd

The Sidney Kimmel Foundation

Dianne C. Bridges

Stanford Frank

Frederick C. Klein

Charles B. Brinkley

Gerald A. Friedman

H. L. Klein

James B. Carson

William J. Gaughan

Stephen B. Klein

James A. Cassel

Milton Goldberg

The Raymond Klein Charitable Foundation

Richard E. Cherin

James J. Golden

Benjamin A. Kohl

Robert I. Chernett

Richard Goldsborough

Herbert Kolsby

Stan Chernett

Joseph S. Gonnella

Gerald Kushner

David I. Cohen

Gretchen R. Goodnow

Thomas J. Kutchner

Theodore B. Cohen

Edward Gosfield

Michael A. Kutell

John R. Cohn

Richard C. Gozon

George P. Lange

Donald S. Collins

Albert Greenbaum

Lee E. Larson
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New Faculty
The Department of Medicine is pleased to
announce that Barry S. Ziring, MD, has
been named the Director of the Division
of Internal Medicine, and Oscar Irigoyen,
MD, has been named the Acting Director
of the Division of Rheumatology.
The Division of Cardiology has two new
faculty: Ira Cohen, MD, and Daniel
Frisch, MD.

Awards and Honors
Five new faculty have joined the Division
of Internal Medicine: Donna Williams,
MD; Jennifer Cowan, MD; Albert Lee,
MD; Taki Galanis, MD; and Nathan
Negin, MD.
The Division of Nephrology welcomes
Won Kook Han, MD, Yonghong L.
Huan, MD, and JuFang Wang, PhD.

Glenn Radice, PhD, has joined the Center
for Translational Medicine.
Wolfgang Bergmeier, PhD, and Saleh
Ayache, MD, have joined the Division
of Hematology.

Thomas Force, MD, the James C.
Wilson Professor of Medicine and
Clinical Director of the Center for
Translational Medicine, received the
“Albrecht Fleckenstein Memorial
Award” for distinguished contribution
to basic research. Members of the
Faculty of the International Academy
of Cardiology — a world-renowned
panel of 140 cardiologists and
scientists — announced the award
during the 13th World Congress on
Heart Disease held in Vancouver in
July 2007.
In September 2007, Nature
Medicine published a paper
by Hui Zhang, MD, PhD, Associate
Professor, Division of Infectious
Diseases and Environmental Medicine,
and his colleagues, suggesting that
cellular microRNAs can help HIV
persist by shutting off viral replication
and contributing to latency. To view
the article online visit www.
nature.com/nm/index.html.

The Division of Infectious Diseases
welcomes Dionissios Neofytos, MD.
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The Division of Endocrinology invites
you to visit the Jefferson Weight
Management Program’s new website at
www.jefferson.edu/endocrinology/
weightmanagement and learn more
about our highly successful options
for losing weight and keeping it off.
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Bernard L. Segal, MD, Director
Center for Outcomes Research
Critical Care, Pulmonary, Allergic,
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Paul E. Marik, MD, Director
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Gastroenterology and Hepatology
Anthony J. DiMarino, MD, Director
Hematology
Paul F. Bray, MD, Director
Hematology/Cardeza Foundation
for Hematologic Research
Infectious Diseases and
Environmental Medicine
Kathleen E. Squires, MD, Director
Center for Biodefense
Center for Human Virology
Internal Medicine
Barry S. Ziring, MD, Director
Center for Vascular Diseases
Nephrology
Joseph Y. Cheung, MD, PhD, Director
Center for Novel Therapies
in Kidney Disease
Rheumatology
Oscar Irigoyen, MD, Acting Director
Center for Translational Medicine
Walter
J. Koch, PhD, FAHA, Director
https://jdc.jefferson.edu/translations/vol3/iss2/1
Vice Chair for Research
W.W. Smith Professor of Medicine
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